A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in China
BNT162b2 (mRNA vaccine) exhibits the highest antibody levels among the five vaccines evaluated, regardless of whether the target is the wild-type virus or its variants. However, its cellular immune response may be weaker compared to CONVIDECIA (adenovirus type 5 vector vaccine).
Authors
- Li Zhou (ORCID: https://orcid.org/0000-0002-6211-1860)
- Hongxing Pan (ORCID: https://orcid.org/0000-0002-3791-1241)
- Xu Han (ORCID: https://orcid.org/0000-0002-1530-2162)
- Siyue Jia (ORCID: https://orcid.org/0000-0002-0648-4507)
- Mingwei Wei
- Shuyu Gao
- Fengcai Zhu (ORCID: https://orcid.org/0000-0002-1644-0006)
- Pengfei Jin (ORCID: https://orcid.org/0000-0002-8908-2633)
- Wen-Juan Wang (ORCID: https://orcid.org/0000-0003-2892-1330)
- Kai Chu
- Jingxin Li (ORCID: https://orcid.org/0000-0002-6911-8387)
Institutions
- Jiangsu Provincial Center for Disease Control and Prevention (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-08-21
- DOI
- https://doi.org/10.3389/fimmu.2024.1455730
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.78